• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症后第一年出现新的慢性护理依赖、呼吸支持依赖、透析依赖及死亡的发生率和危险因素

Occurrence and Risk Factors for New Dependency on Chronic Care, Respiratory Support, Dialysis and Mortality in the First Year After Sepsis.

作者信息

Spoden Melissa, Hartog Christiane S, Schlattmann Peter, Freytag Antje, Ostermann Marlies, Wedekind Lisa, Storch Josephine, Reinhart Konrad, Günster Christian, Fleischmann-Struzek Carolin

机构信息

Research Institute of the Local Health Care Funds (AOK), Berlin, Germany.

Department of Anesthesiology and Operative Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Front Med (Lausanne). 2022 May 19;9:878337. doi: 10.3389/fmed.2022.878337. eCollection 2022.

DOI:10.3389/fmed.2022.878337
PMID:35665356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9162443/
Abstract

Sepsis survival is associated with adverse outcomes. Knowledge about risk factors for adverse outcomes is lacking. We performed a population-based cohort study of 116,507 survivors of hospital-treated sepsis identified in health claims data of a German health insurance provider. We determined the development and risk factors for long-term adverse events: new dependency on chronic care, chronic dialysis, long-term respiratory support, and 12-month mortality. At-risk patients were defined by absence of these conditions prior to sepsis. Risk factors were identified using simple and multivariable logistic regression analyses. In the first year post-sepsis, 48.9% (56,957) of survivors had one or more adverse outcome, including new dependency on chronic care (31.9%), dialysis (2.8%) or respiratory support (1.6%), and death (30.7%). While pre-existing comorbidities adversely affected all studied outcomes (>4 comorbidities: OR 3.2 for chronic care, OR 4.9 for dialysis, OR 2.7 for respiratory support, OR 4.7 for 12-month mortality), increased age increased the odds for chronic care dependency and 12-month mortality, but not for dialysis or respiratory support. Hospital-acquired and multi-resistant infections were associated with increased risk of chronic care dependency, dialysis, and 12-month mortality. Multi-resistant infections also increased the odds of respiratory support. Urinary or respiratory infections or organ dysfunction increased the odds of new dialysis or respiratory support, respectively. Central nervous system infection and organ dysfunction had the highest OR for chronic care dependency among all infections and organ dysfunctions. Our results imply that patient- and infection-related factors have a differential impact on adverse life changing outcomes after sepsis. There is an urgent need for targeted interventions to reduce the risk.

摘要

脓毒症幸存者常伴有不良后果。目前尚缺乏关于不良后果风险因素的相关知识。我们基于德国一家健康保险公司的健康理赔数据,对116,507名接受过医院治疗的脓毒症幸存者进行了一项队列研究。我们确定了长期不良事件的发生情况及风险因素,包括对长期护理的新依赖、慢性透析、长期呼吸支持以及12个月死亡率。有风险的患者定义为在脓毒症发作前不存在这些情况。通过简单和多变量逻辑回归分析确定风险因素。在脓毒症后的第一年,48.9%(56,957名)幸存者出现了一种或多种不良后果,包括对长期护理的新依赖(31.9%)、透析(2.8%)或呼吸支持(1.6%)以及死亡(30.7%)。虽然既往合并症对所有研究结果均有不利影响(>4种合并症:长期护理的比值比为3.2,透析为4.9,呼吸支持为2.7,12个月死亡率为4.7),但年龄增加会增加长期护理依赖和12个月死亡率的几率,但对透析或呼吸支持无此影响。医院获得性感染和多重耐药感染与长期护理依赖、透析和12个月死亡率的风险增加相关。多重耐药感染也增加了呼吸支持的几率。泌尿系统或呼吸系统感染或器官功能障碍分别增加了新透析或呼吸支持的几率。在所有感染和器官功能障碍中,中枢神经系统感染和器官功能障碍导致长期护理依赖的比值比最高。我们的结果表明,患者相关因素和感染相关因素对脓毒症后改变生活的不良后果有不同影响。迫切需要采取针对性干预措施以降低风险。

相似文献

1
Occurrence and Risk Factors for New Dependency on Chronic Care, Respiratory Support, Dialysis and Mortality in the First Year After Sepsis.脓毒症后第一年出现新的慢性护理依赖、呼吸支持依赖、透析依赖及死亡的发生率和危险因素
Front Med (Lausanne). 2022 May 19;9:878337. doi: 10.3389/fmed.2022.878337. eCollection 2022.
2
Risk Factors at Index Hospitalization Associated With Longer-term Mortality in Adult Sepsis Survivors.索引住院期间的危险因素与成人脓毒症幸存者的长期死亡率相关。
JAMA Netw Open. 2019 May 3;2(5):e194900. doi: 10.1001/jamanetworkopen.2019.4900.
3
Epidemiology and Costs of Postsepsis Morbidity, Nursing Care Dependency, and Mortality in Germany, 2013 to 2017.德国 2013 至 2017 年脓毒症发病后发病率、护理依赖和死亡率的流行病学和成本
JAMA Netw Open. 2021 Nov 1;4(11):e2134290. doi: 10.1001/jamanetworkopen.2021.34290.
4
Development, Validation, and Clinical Utility Assessment of a Prognostic Score for 1-Year Unplanned Rehospitalization or Death of Adult Sepsis Survivors.成人脓毒症幸存者1年非计划再住院或死亡预后评分的开发、验证及临床效用评估
JAMA Netw Open. 2020 Sep 1;3(9):e2013580. doi: 10.1001/jamanetworkopen.2020.13580.
5
Development and validation of risk-adjusted quality indicators for the long-term outcome of acute sepsis care in German hospitals based on health claims data.基于健康保险理赔数据的德国医院急性脓毒症护理长期结局风险调整质量指标的开发与验证
Front Med (Lausanne). 2023 Jan 9;9:1069042. doi: 10.3389/fmed.2022.1069042. eCollection 2022.
6
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
7
The Impact of Acute Organ Dysfunction on Long-Term Survival in Sepsis.急性器官功能障碍对脓毒症患者长期生存的影响。
Crit Care Med. 2018 Jun;46(6):843-849. doi: 10.1097/CCM.0000000000003023.
8
A Comparison of Mortality From Sepsis in Brazil and England: The Impact of Heterogeneity in General and Sepsis-Specific Patient Characteristics.巴西和英国脓毒症死亡率的比较:一般和脓毒症特异性患者特征的异质性的影响。
Crit Care Med. 2019 Jan;47(1):76-84. doi: 10.1097/CCM.0000000000003438.
9
Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare.脓毒症性休克、败血症和严重感染住院幸存者的长期死亡率和结局:后续护理的重要性。
PLoS One. 2020 Feb 12;15(2):e0228952. doi: 10.1371/journal.pone.0228952. eCollection 2020.
10
Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study.手术部位感染导致的表型异质性:一项前瞻性纵向研究。
Crit Care. 2020 May 7;24(1):203. doi: 10.1186/s13054-020-02917-3.

引用本文的文献

1
Be-SNAP: the Belgian Sepsis National Action Plan.比利时脓毒症国家行动计划(Be-SNAP)
Front Public Health. 2025 Jul 1;13:1575502. doi: 10.3389/fpubh.2025.1575502. eCollection 2025.
2
Sepsis in Latvia-Incidence, Outcomes, and Healthcare Utilization: A Retrospective, Observational Study.拉脱维亚的脓毒症——发病率、结局及医疗保健利用情况:一项回顾性观察研究
Healthcare (Basel). 2024 Jan 21;12(2):272. doi: 10.3390/healthcare12020272.
3
Most patients with an increased risk for sepsis-related morbidity or death do not recognize sepsis as a medical emergency: results of a survey study using case vignettes.

本文引用的文献

1
Epidemiology and Costs of Postsepsis Morbidity, Nursing Care Dependency, and Mortality in Germany, 2013 to 2017.德国 2013 至 2017 年脓毒症发病后发病率、护理依赖和死亡率的流行病学和成本
JAMA Netw Open. 2021 Nov 1;4(11):e2134290. doi: 10.1001/jamanetworkopen.2021.34290.
2
Prediction Models for Physical, Cognitive, and Mental Health Impairments After Critical Illness: A Systematic Review and Critical Appraisal.重症后身体、认知和心理健康损伤的预测模型:系统评价和批判性评估。
Crit Care Med. 2020 Dec;48(12):1871-1880. doi: 10.1097/CCM.0000000000004659.
3
Risk Factors for Long-term Mortality and Patterns of End-of-Life Care Among Medicare Sepsis Survivors Discharged to Home Health Care.
大多数有发生脓毒症相关发病率或死亡率增加风险的患者并未将脓毒症识别为医疗紧急情况:使用病例简述进行的调查研究结果。
Crit Care. 2023 Nov 17;27(1):446. doi: 10.1186/s13054-023-04733-x.
4
Challenges of assessing the burden of sepsis.评估脓毒症负担面临的挑战。
Med Klin Intensivmed Notfmed. 2023 Dec;118(Suppl 2):68-74. doi: 10.1007/s00063-023-01088-7. Epub 2023 Nov 17.
5
Differences in Mortality and Sepsis-Associated Organ Dysfunction between Surgical and Non-Surgical Sepsis Patients.手术和非手术脓毒症患者在死亡率及脓毒症相关器官功能障碍方面的差异。
Biomedicines. 2023 Aug 9;11(8):2233. doi: 10.3390/biomedicines11082233.
6
Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis.基于生物信息数据分析的脓毒症生物标志物筛选。
J Healthc Eng. 2022 Sep 26;2022:6788569. doi: 10.1155/2022/6788569. eCollection 2022.
7
Prevalence and Long-Term Prognosis of Post-Intensive Care Syndrome after Sepsis: A Single-Center Prospective Observational Study.脓毒症后重症监护综合征的患病率及长期预后:一项单中心前瞻性观察研究
J Clin Med. 2022 Sep 6;11(18):5257. doi: 10.3390/jcm11185257.
医疗保险脓毒症幸存者出院后居家医疗的长期死亡率风险因素和临终关怀模式。
JAMA Netw Open. 2020 Feb 5;3(2):e200038. doi: 10.1001/jamanetworkopen.2020.0038.
4
Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012-2018.医疗保险受益人群中的脓毒症:2. 2012-2018 年脓毒症的轨迹。
Crit Care Med. 2020 Mar;48(3):289-301. doi: 10.1097/CCM.0000000000004226.
5
Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysis.脓毒症幸存者再入院的比率和风险因素:系统评价和荟萃分析。
Intensive Care Med. 2020 Apr;46(4):619-636. doi: 10.1007/s00134-019-05908-3. Epub 2020 Jan 23.
6
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
7
Post-sepsis syndrome - an evolving entity that afflicts survivors of sepsis.败血症后综合征——一种困扰败血症幸存者的不断演变的实体。
Mol Med. 2019 Dec 31;26(1):6. doi: 10.1186/s10020-019-0132-z.
8
Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice.理解和改善脓毒症幸存者状况。研究和实践的优先事项。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):972-981. doi: 10.1164/rccm.201812-2383CP.
9
Risk Factors at Index Hospitalization Associated With Longer-term Mortality in Adult Sepsis Survivors.索引住院期间的危险因素与成人脓毒症幸存者的长期死亡率相关。
JAMA Netw Open. 2019 May 3;2(5):e194900. doi: 10.1001/jamanetworkopen.2019.4900.
10
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis.新型败血症临床表型的推导、验证及潜在治疗意义。
JAMA. 2019 May 28;321(20):2003-2017. doi: 10.1001/jama.2019.5791.